Literature DB >> 3024172

Purification of a benzodiazepine from bovine brain and detection of benzodiazepine-like immunoreactivity in human brain.

L Sangameswaran, H M Fales, P Friedrich, A L De Blas.   

Abstract

An endogenous brain substance that binds to the central-type benzodiazepine receptors with agonist properties is present in both rat and bovine brains. This substance has been purified to homogeneity from bovine brain by immunoaffinity chromatography on immobilized monoclonal anti-benzodiazepine antibody followed by gel filtration on Sephadex G-25 and two reversed-phase HPLC steps. The purified substance was characterized as the benzodiazepine N-desmethyldiazepam (nordiazepam). The techniques used for the identification were mass spectrometry, HPLC, spectrophotometry, benzodiazepine receptor binding, and immunological techniques. Benzodiazepine-like immunoreactivity was also found in all the human brains tested, including six brains that had been stored in paraffin since 1940, fifteen years before the first synthesis of benzodiazepines. These results show that benzodiazepine-like molecules of natural origin--and possibly benzodiazepines themselves--are present in human and other mammalian brains.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024172      PMCID: PMC387110          DOI: 10.1073/pnas.83.23.9236

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Antibodies as a means of isolating and characterizing biologically active substances: presence of a non-peptide, morphine-like compound in the central nervous system.

Authors:  A R Gintzler; A Levy; S Spector
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

2.  Benzodiazepine receptor: demonstration in the central nervous system.

Authors:  H Möhler; T Okada
Journal:  Science       Date:  1977-11-25       Impact factor: 47.728

3.  A nonpeptide morphine-like compound: immunocytochemical localization in the mouse brain.

Authors:  A R Gintzler; M D Gershon; S Spector
Journal:  Science       Date:  1978-01-27       Impact factor: 47.728

4.  Monoclonal antibodies to specific astroglial and neuronal antigens reveal the cytoarchitecture of the Bergmann glia fibers in the cerebellum.

Authors:  A L de Blas
Journal:  J Neurosci       Date:  1984-01       Impact factor: 6.167

5.  Morphine and other opiates from beef brain and adrenal.

Authors:  A Goldstein; R W Barrett; I F James; L I Lowney; C J Weitz; L L Knipmeyer; H Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

6.  Monoclonal antibodies to benzodiazepines.

Authors:  A L De Blas; L Sangameswaran; S A Haney; D Park; C J Abraham; C A Rayner
Journal:  J Neurochem       Date:  1985-12       Impact factor: 5.372

7.  Demonstration of benzodiazepine-like molecules in the mammalian brain with a monoclonal antibody to benzodiazepines.

Authors:  L Sangameswaran; A L de Blas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

8.  Presence and formation of codeine and morphine in the rat.

Authors:  J Donnerer; K Oka; A Brossi; K C Rice; S Spector
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

9.  Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors.

Authors:  A Guidotti; C M Forchetti; M G Corda; D Konkel; C D Bennett; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Morphine in cow and human milk: could dietary morphine constitute a ligand for specific morphine (mu) receptors?

Authors:  E Hazum; J J Sabatka; K J Chang; D A Brent; J W Findlay; P Cuatrecasas
Journal:  Science       Date:  1981-08-28       Impact factor: 47.728

View more
  19 in total

1.  In vivo formation of diazepam-like 1,4-benzodiazepines by Penicillium verrucosum var. verrucosum after administration of 2-aminobenzophenones and glycine.

Authors:  G Bringmann; T Mader
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  The effect of intravenous flumazenil on interictal electroencephalographic epileptic activity: results of a placebo-controlled study.

Authors:  Y M Hart; H Meinardi; J W Sander; D J Nutt; S D Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

3.  Novel dihydropyrimidine derivatives as potential HDAC inhibitors: in silico study.

Authors:  Ganapathi Thipparapu; Rajanna Ajumeera; Vijayalakshmi Venkatesan
Journal:  In Silico Pharmacol       Date:  2017-10-12

Review 4.  Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy.

Authors:  J D Rothstein; M Olasmaa
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

5.  Purification and characterization of a benzodiazepine-like substance from mammalian brain.

Authors:  C C Liao; H S Lin; J Y Liu; L S Hibbard; J Y Wu
Journal:  Neurochem Res       Date:  1989-04       Impact factor: 3.996

6.  [Do benzodiazepines represent "natural" drugs?].

Authors:  U Klotz
Journal:  Klin Wochenschr       Date:  1989-01-20

7.  Diazepam and N-desmethyldiazepam are found in rat brain and adrenal and may be of plant origin.

Authors:  J Wildmann; H Möhler; W Vetter; U Ranalder; K Schmidt; R Maurer
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

Review 8.  Benzodiazepines in the brain. Their origin and possible biological roles.

Authors:  J H Medina; C Peña; M Piva; C Wolfman; M L de Stein; C Wasowski; C Da Cunha; I Izquierdo; A C Paladini
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

Review 9.  Natural endogenous ligands for benzodiazepine receptors in hepatic encephalopathy.

Authors:  M Baraldi; R Avallone; L Corsi; I Venturini; C Baraldi; M L Zeneroli
Journal:  Metab Brain Dis       Date:  2008-12-11       Impact factor: 3.584

10.  Chemical substructures that enrich for biological activity.

Authors:  Justin Klekota; Frederick P Roth
Journal:  Bioinformatics       Date:  2008-09-10       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.